Clonazepam
Brand names: Rivotril
Clonazepam is a long-acting benzodiazepine used for certain seizure types and selected other indications.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
US labelling (FDA)
Reference — US labelling, may differ from UKDOSAGE AND ADMINISTRATION Clonazepam is available as a tablet. The tablets should be administered with water by swallowing the tablet whole. Seizure Disorders: The use of multiple anticonvulsants may result in an increase of CNS depressant adverse effects. This should be considered before adding clonazepam tablets to an existing anticonvulsant regimen. Adults: The initial dose for adults with seizure disorders should not exceed 1.5 mg/day divided into three doses. Dosage may be increased in increments of 0.5 mg to 1 mg every 3 days until seizures are adequately controlled or until side effects preclude any further increase. Maintenance dosage must be individualized for each patient …
Source: US FDA prescribing information (openFDA / DailyMed), label dated 2026-03-16. Accessed 2026-06-12. US dosing and indications can differ from UK practice — use UK sources for prescribing decisions.
Clinical monograph
How it works
It enhances the inhibitory action of GABA at the GABA-A receptor, increasing neuronal inhibition.
Prescribing in practice
- Sedation, tolerance and dependence limit it — use the lowest effective dose for the shortest appropriate time.
- Dangerous respiratory depression can occur with opioids or alcohol.
- Do not stop it abruptly (risk of withdrawal seizures); it causes falls and confusion in older people.
Monitoring
Review the ongoing need regularly, along with sedation, mood and signs of dependence.
Counselling the patient
- Do not stop it suddenly.
- Avoid alcohol; it is dangerous combined with opioid painkillers.
- It impairs driving and operating machinery.
Evidence & guidelines
Used for specific epilepsy indications and selected other uses, mindful of dependence (NICE NG217).
Reference: NICE NG217; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Acute Stroke / TIA Assessment · NICE NG128; RCP Stroke Guidelines 2023
- Status Epilepticus (Adults) · NICE CG137; ESEM guidelines; RCP Neurology Guidelines
- Suspected Subarachnoid Haemorrhage · NICE NG228; RCEM 2023; AHA/ASA 2023
- Adult Head Injury · NICE NG232 (2023)
- Bell's Palsy / Facial Nerve Palsy · ENT UK 2017; AAN
- Vertigo Workup · ENT UK; NICE CKS